Intec Pharma Expands Intellectual Property for AP-CDLD with Patent in South Korea

JERUSALEM, Israel, April 6, 2016 /PRNewswire/ —

Intec Pharma Ltd. (NASDAQ: NTEC) (TASE: INTP), a clinical-stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology, today announced that the company has been informed that the…
Source: PRNewsWire-USA

Intec Pharma Expands Intellectual Property for AP-CDLD with Patent in South Korea